L. Weir

发表

Synthesis and activity of new aryl- and heteroaryl-substituted pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain.

M. Vieth, R. Campbell, B. Anderson, 2003, Journal of medicinal chemistry.

D-Phe-Pro-p-Amidinobenzylamine: A potent and highly selective thrombin inhibitor

N. Chirgadze, D. Clawson, N. D. Jones, 1996 .

Sulfonimidamide analogs of oncolytic sulfonylureas.

S. B. Gates, R. Schultz, L. Weir, 1997, Journal of medicinal chemistry.

Anthranilamide inhibitors of factor Xa.

J. A. Kyle, J. Masters, T. Goodson, 2007, Bioorganic & medicinal chemistry letters.

1,2-Dibenzamidobenzene inhibitors of human factor Xa.

J. A. Kyle, J. Wikel, B. Eastwood, 2000, Journal of medicinal chemistry.

N(2)-Aroylanthranilamide inhibitors of human factor Xa.

J. A. Kyle, T. Goodson, T. Craft, 2000, Journal of medicinal chemistry.

Investigation of factor Xa inhibitors containing non-amidine S1 elements.

R. Towner, J. Masters, T. Craft, 2005, Bioorganic & medicinal chemistry letters.

SERINE PROTEASE SELECTIVITY OF THE THROMBIN INHIBITOR D-PHE-PRO-AGMATINE AND ITS HOMOLOGS

A. Schacht, N. Chirgadze, D. Clawson, 1995 .

1,2-Dibenzamidobenzene inhibitors of human factor Xa.

J. A. Kyle, J. Wikel, B. Eastwood, 2000, Journal of medicinal chemistry.

Structure-based design of potent, amidine-derived inhibitors of factor Xa: evaluation of selectivity, anticoagulant activity, and antithrombotic activity.

J. A. Kyle, N. Chirgadze, S. Briggs, 2000, Journal of Medicinal Chemistry.

Control of Armillaria and Phellinus root diseases: 20-year results from the Skimikin stump removal experiment.

L. Weir, D. Morrison, G. M. Wallis, 1988 .

The design of potent, selective, non-covalent, peptide thrombin inhibitors utilizing imidazole as a S1 binding element.

A. Schacht, N. Chirgadze, S. Briggs, 1999, Bioorganic & medicinal chemistry letters.

N-substituted glycines as replacements for proline in tripeptide aldehyde thrombin inhibitors

A. Schacht, N. Chirgadze, D. Clawson, 1995 .

Structure-based design of potent, amidine-derived inhibitors of factor Xa: evaluation of selectivity, anticoagulant activity, and antithrombotic activity.

J. A. Kyle, Michael Robert Wiley, N. Chirgadze, 2000, Journal of Medicinal Chemistry.